<p>The U.S. Food and Drug Administration has called for an assessment of potential neurocognitive side effects of an experimental cholesterol drug being developed by Regeneron and Sanofi, Sanofi said...
An FDA advisory committee has voted in favor of changing the labeling language warning of possible heart issues while taking NSAIDs after reviewing, and refuting, a new study.
Millions of patients with relapsing forms of multiple sclerosis won’t have to endure daily injections any longer, thanks to a new drug application approved by the U.S. Food and Drug Administration.
<p>The U.S. Food and Drug Administration proposed a new rule to better regulate and set safety standards in the manufacture of infant formula products.</p>
